Eli Lilly
LLY
4,357 hedge funds and large institutions have $714B invested in Eli Lilly in 2026 Q1 according to their latest regulatory filings, with 237 funds opening new positions, 1,937 increasing their positions, 1,697 reducing their positions, and 229 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 1,937 | Existing positions reduced: 1,697
3% more first-time investments, than exits
New positions opened: 237 | Existing positions closed: 229
1.46% less ownership
Funds ownership: 83.6% → 82.15% (-1.5%)
2% less funds holding
Funds holding: 4,430 → 4,357 (-73)
16% less capital invested
Capital invested by funds: $848B → $714B (-$134B)
23% less funds holding in top 10
Funds holding in top 10: 488 → 376 (-112)
29% less call options, than puts
Call options by funds: $9.52B | Put options by funds: $13.4B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$1.52B |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.23B |
| 3 |
DAM
Diamant Asset Management
Ridgefield,
Connecticut
|
+$1.08B |
| 4 |
JP Morgan Chase
New York
|
+$710M |
| 5 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$647M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSC
J. Stern & Co
London,
United Kingdom
|
-$4.1B |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$3.8B |
| 3 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$1.74B |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$1.5B |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$931M |
LLY Hedge Fund Activity: Q1 2026 in Review
4,357 of the 8,138 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2026, worth a combined $714B — down 16% from $848B a quarter earlier.
Buyers outnumbered sellers: 237 funds opened new LLY positions and 229 closed out — a net gain of 8 holders — while 1,937 added to existing stakes and 1,697 trimmed.
The largest buyer was Fifth Third Bancorp, adding an estimated $1.52B. The largest seller was J. Stern & Co, cutting an estimated $4.1B.
- 4,357 institutional investors held Eli Lilly (LLY) as of Q1 2026, down from 4,430 in Q4 2025.
- Funds reported $714B of Eli Lilly stock for Q1 2026, down 16% quarter-over-quarter.
- 237 funds opened new Eli Lilly positions in Q1 2026 and 229 closed out, a net change of +8 holders.
- The largest Eli Lilly buyer in Q1 2026 was Fifth Third Bancorp, an estimated $1.52B added.
- The largest Eli Lilly seller in Q1 2026 was J. Stern & Co, an estimated $4.1B sold.
Based on aggregated 13F filings for Q1 2026.